Leptin upregulates tissue factor expression in human breast cancer MCF-7 cells

Emanuela Napoleone, Antonella Cutrone, Daniela Cugino, Maria Carmela Latella, Filomena Zurlo, Licia Iacoviello, Giovanni De Gaetano, Maria Benedetta Donati, Roberto Lorenzet

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Introduction: Obesity is a risk factor for both cardiovascular disease and cancer development. Leptin, a cytokine produced by adipose tissue, controls different processes in peripheral tissues, including cancer development and thrombotic disorders in patients with a variety of clinical disorders. Tissue factor (TF), the trigger of blood clotting, is abundant in the adipose tissue. Since TF, often expressed by cancer cells, is considered a hallmark of cancer progression, we investigated whether leptin could modulate TF in the human metastatic breast carcinoma cell line MCF-7. Materials and Methods: MCF-7 cells were incubated with or without the different reagents at 37 °C. At the end of incubation, cells were tested for procoagulant activity by a one-stage clotting assay, TF and TNF-α antigen levels and mRNA by ELISA and real-time RT-PCR, respectively. Leptin receptor was studied by FACS. Results: Both TF activity and antigen constitutively expressed by MCF-7 were significantly increased by leptin in a dose-dependent fashion. TF mRNA levels were also enhanced indicating that leptin exerts its effect at the transcription level. The effect of leptin was specific and required binding to its receptor (Ob-R), which was found on the surface of the cells, since antibodies against leptin and Ob-R completely prevented TF expression upregulation. In addition, leptin enhanced both TNF-α mRNA synthesis and secretion from MCF7. An anti-TNF-α MoAb completely abolished the leptin-induced TF expression. Conclusions: These data support the hypothesis that leptin, by its upregulation of TF, possibly mediated by TNF-α synthesis, may contribute to processes underlying both cancer and vascular cell disorders.

Original languageEnglish
Pages (from-to)641-647
Number of pages7
JournalThrombosis Research
Volume129
Issue number5
DOIs
Publication statusPublished - May 2012

Fingerprint

MCF-7 Cells
Thromboplastin
Leptin
Up-Regulation
Breast Neoplasms
Neoplasms
Messenger RNA
Adipose Tissue
Antigens
Leptin Receptors
Blood Coagulation
Blood Vessels
Real-Time Polymerase Chain Reaction
Cardiovascular Diseases
Obesity
Enzyme-Linked Immunosorbent Assay
Cytokines
Cell Line
Antibodies

Keywords

  • Breast cancer
  • Leptin
  • MCF-7
  • Thrombogenesis
  • Tissue factor
  • TNF-α

ASJC Scopus subject areas

  • Hematology

Cite this

Napoleone, E., Cutrone, A., Cugino, D., Latella, M. C., Zurlo, F., Iacoviello, L., ... Lorenzet, R. (2012). Leptin upregulates tissue factor expression in human breast cancer MCF-7 cells. Thrombosis Research, 129(5), 641-647. https://doi.org/10.1016/j.thromres.2011.07.037

Leptin upregulates tissue factor expression in human breast cancer MCF-7 cells. / Napoleone, Emanuela; Cutrone, Antonella; Cugino, Daniela; Latella, Maria Carmela; Zurlo, Filomena; Iacoviello, Licia; De Gaetano, Giovanni; Donati, Maria Benedetta; Lorenzet, Roberto.

In: Thrombosis Research, Vol. 129, No. 5, 05.2012, p. 641-647.

Research output: Contribution to journalArticle

Napoleone, Emanuela ; Cutrone, Antonella ; Cugino, Daniela ; Latella, Maria Carmela ; Zurlo, Filomena ; Iacoviello, Licia ; De Gaetano, Giovanni ; Donati, Maria Benedetta ; Lorenzet, Roberto. / Leptin upregulates tissue factor expression in human breast cancer MCF-7 cells. In: Thrombosis Research. 2012 ; Vol. 129, No. 5. pp. 641-647.
@article{c07d2c8b4870476eaab8f81e2a664bbb,
title = "Leptin upregulates tissue factor expression in human breast cancer MCF-7 cells",
abstract = "Introduction: Obesity is a risk factor for both cardiovascular disease and cancer development. Leptin, a cytokine produced by adipose tissue, controls different processes in peripheral tissues, including cancer development and thrombotic disorders in patients with a variety of clinical disorders. Tissue factor (TF), the trigger of blood clotting, is abundant in the adipose tissue. Since TF, often expressed by cancer cells, is considered a hallmark of cancer progression, we investigated whether leptin could modulate TF in the human metastatic breast carcinoma cell line MCF-7. Materials and Methods: MCF-7 cells were incubated with or without the different reagents at 37 °C. At the end of incubation, cells were tested for procoagulant activity by a one-stage clotting assay, TF and TNF-α antigen levels and mRNA by ELISA and real-time RT-PCR, respectively. Leptin receptor was studied by FACS. Results: Both TF activity and antigen constitutively expressed by MCF-7 were significantly increased by leptin in a dose-dependent fashion. TF mRNA levels were also enhanced indicating that leptin exerts its effect at the transcription level. The effect of leptin was specific and required binding to its receptor (Ob-R), which was found on the surface of the cells, since antibodies against leptin and Ob-R completely prevented TF expression upregulation. In addition, leptin enhanced both TNF-α mRNA synthesis and secretion from MCF7. An anti-TNF-α MoAb completely abolished the leptin-induced TF expression. Conclusions: These data support the hypothesis that leptin, by its upregulation of TF, possibly mediated by TNF-α synthesis, may contribute to processes underlying both cancer and vascular cell disorders.",
keywords = "Breast cancer, Leptin, MCF-7, Thrombogenesis, Tissue factor, TNF-α",
author = "Emanuela Napoleone and Antonella Cutrone and Daniela Cugino and Latella, {Maria Carmela} and Filomena Zurlo and Licia Iacoviello and {De Gaetano}, Giovanni and Donati, {Maria Benedetta} and Roberto Lorenzet",
year = "2012",
month = "5",
doi = "10.1016/j.thromres.2011.07.037",
language = "English",
volume = "129",
pages = "641--647",
journal = "Thrombosis Research",
issn = "0049-3848",
publisher = "Elsevier Limited",
number = "5",

}

TY - JOUR

T1 - Leptin upregulates tissue factor expression in human breast cancer MCF-7 cells

AU - Napoleone, Emanuela

AU - Cutrone, Antonella

AU - Cugino, Daniela

AU - Latella, Maria Carmela

AU - Zurlo, Filomena

AU - Iacoviello, Licia

AU - De Gaetano, Giovanni

AU - Donati, Maria Benedetta

AU - Lorenzet, Roberto

PY - 2012/5

Y1 - 2012/5

N2 - Introduction: Obesity is a risk factor for both cardiovascular disease and cancer development. Leptin, a cytokine produced by adipose tissue, controls different processes in peripheral tissues, including cancer development and thrombotic disorders in patients with a variety of clinical disorders. Tissue factor (TF), the trigger of blood clotting, is abundant in the adipose tissue. Since TF, often expressed by cancer cells, is considered a hallmark of cancer progression, we investigated whether leptin could modulate TF in the human metastatic breast carcinoma cell line MCF-7. Materials and Methods: MCF-7 cells were incubated with or without the different reagents at 37 °C. At the end of incubation, cells were tested for procoagulant activity by a one-stage clotting assay, TF and TNF-α antigen levels and mRNA by ELISA and real-time RT-PCR, respectively. Leptin receptor was studied by FACS. Results: Both TF activity and antigen constitutively expressed by MCF-7 were significantly increased by leptin in a dose-dependent fashion. TF mRNA levels were also enhanced indicating that leptin exerts its effect at the transcription level. The effect of leptin was specific and required binding to its receptor (Ob-R), which was found on the surface of the cells, since antibodies against leptin and Ob-R completely prevented TF expression upregulation. In addition, leptin enhanced both TNF-α mRNA synthesis and secretion from MCF7. An anti-TNF-α MoAb completely abolished the leptin-induced TF expression. Conclusions: These data support the hypothesis that leptin, by its upregulation of TF, possibly mediated by TNF-α synthesis, may contribute to processes underlying both cancer and vascular cell disorders.

AB - Introduction: Obesity is a risk factor for both cardiovascular disease and cancer development. Leptin, a cytokine produced by adipose tissue, controls different processes in peripheral tissues, including cancer development and thrombotic disorders in patients with a variety of clinical disorders. Tissue factor (TF), the trigger of blood clotting, is abundant in the adipose tissue. Since TF, often expressed by cancer cells, is considered a hallmark of cancer progression, we investigated whether leptin could modulate TF in the human metastatic breast carcinoma cell line MCF-7. Materials and Methods: MCF-7 cells were incubated with or without the different reagents at 37 °C. At the end of incubation, cells were tested for procoagulant activity by a one-stage clotting assay, TF and TNF-α antigen levels and mRNA by ELISA and real-time RT-PCR, respectively. Leptin receptor was studied by FACS. Results: Both TF activity and antigen constitutively expressed by MCF-7 were significantly increased by leptin in a dose-dependent fashion. TF mRNA levels were also enhanced indicating that leptin exerts its effect at the transcription level. The effect of leptin was specific and required binding to its receptor (Ob-R), which was found on the surface of the cells, since antibodies against leptin and Ob-R completely prevented TF expression upregulation. In addition, leptin enhanced both TNF-α mRNA synthesis and secretion from MCF7. An anti-TNF-α MoAb completely abolished the leptin-induced TF expression. Conclusions: These data support the hypothesis that leptin, by its upregulation of TF, possibly mediated by TNF-α synthesis, may contribute to processes underlying both cancer and vascular cell disorders.

KW - Breast cancer

KW - Leptin

KW - MCF-7

KW - Thrombogenesis

KW - Tissue factor

KW - TNF-α

UR - http://www.scopus.com/inward/record.url?scp=84857783772&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857783772&partnerID=8YFLogxK

U2 - 10.1016/j.thromres.2011.07.037

DO - 10.1016/j.thromres.2011.07.037

M3 - Article

VL - 129

SP - 641

EP - 647

JO - Thrombosis Research

JF - Thrombosis Research

SN - 0049-3848

IS - 5

ER -